Taraban VY - Search Results

1

Expression of TNFRSF25 on conventional T cells and Tregs.

Taraban VY, Ferdinand JR, Al-Shamkhani A. Taraban VY, et al. J Clin Invest. 2011 Feb;121(2):463-4; author reply 465. doi: 10.1172/JCI45832. Epub 2011 Feb 1. J Clin Invest. 2011. PMID: 21285518 Free PMC article. No abstract available.

2

Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.

Slebioda TJ, Rowley TF, Ferdinand JR, Willoughby JE, Buchan SL, Taraban VY, Al-Shamkhani A. Slebioda TJ, et al. Among authors: taraban vy. Eur J Immunol. 2011 Sep;41(9):2606-11. doi: 10.1002/eji.201141477. Epub 2011 Aug 4. Eur J Immunol. 2011. PMID: 21688261 Free article.

3

Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.

Taraban VY, Slebioda TJ, Willoughby JE, Buchan SL, James S, Sheth B, Smyth NR, Thomas GJ, Wang EC, Al-Shamkhani A. Taraban VY, et al. Mucosal Immunol. 2011 Mar;4(2):186-96. doi: 10.1038/mi.2010.70. Epub 2010 Oct 20. Mucosal Immunol. 2011. PMID: 20962771 Free PMC article.

4

Requirement for CD70 in CD4+ Th cell-dependent and innate receptor-mediated CD8+ T cell priming.

Taraban VY, Rowley TF, Tough DF, Al-Shamkhani A. Taraban VY, et al. J Immunol. 2006 Sep 1;177(5):2969-75. doi: 10.4049/jimmunol.177.5.2969. J Immunol. 2006. PMID: 16920932

5

Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation.

French RR, Taraban VY, Crowther GR, Rowley TF, Gray JC, Johnson PW, Tutt AL, Al-Shamkhani A, Glennie MJ. French RR, et al. Among authors: taraban vy. Blood. 2007 Jun 1;109(11):4810-5. doi: 10.1182/blood-2006-11-057216. Epub 2007 Feb 20. Blood. 2007. PMID: 17311995 Free article.

6

The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.

Bull MJ, Williams AS, Mecklenburgh Z, Calder CJ, Twohig JP, Elford C, Evans BA, Rowley TF, Slebioda TJ, Taraban VY, Al-Shamkhani A, Wang EC. Bull MJ, et al. Among authors: taraban vy. J Exp Med. 2008 Oct 27;205(11):2457-64. doi: 10.1084/jem.20072378. Epub 2008 Sep 29. J Exp Med. 2008. PMID: 18824582 Free PMC article.

7

Death receptor 3 is essential for generating optimal protective CD4⁺ T-cell immunity against Salmonella.

Buchan SL, Taraban VY, Slebioda TJ, James S, Cunningham AF, Al-Shamkhani A. Buchan SL, et al. Among authors: taraban vy. Eur J Immunol. 2012 Mar;42(3):580-8. doi: 10.1002/eji.201041950. Epub 2012 Jan 19. Eur J Immunol. 2012. PMID: 22259035 Free article.

8

CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.

Polak ME, Newell L, Taraban VY, Pickard C, Healy E, Friedmann PS, Al-Shamkhani A, Ardern-Jones MR. Polak ME, et al. Among authors: taraban vy. J Invest Dermatol. 2012 Jun;132(6):1636-44. doi: 10.1038/jid.2012.26. Epub 2012 Mar 1. J Invest Dermatol. 2012. PMID: 22377764 Free article.

9

CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization.

Taraban VY, Rowley TF, Kerr JP, Willoughby JE, Johnson PM, Al-Shamkhani A, Buchan SL. Taraban VY, et al. Eur J Immunol. 2013 Dec;43(12):3314-23. doi: 10.1002/eji.201343579. Epub 2013 Oct 1. Eur J Immunol. 2013. PMID: 24002868 Free article.

10

Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization.

Willoughby JE, Kerr JP, Rogel A, Taraban VY, Buchan SL, Johnson PW, Al-Shamkhani A. Willoughby JE, et al. Among authors: taraban vy. J Immunol. 2014 Jul 1;193(1):244-51. doi: 10.4049/jimmunol.1301217. Epub 2014 May 23. J Immunol. 2014. PMID: 24860188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters